Fullgent Genetics (FLGT) Crossed Above the 200-Day Moving Average: What That Means for InvestorsZacks Investment Research • 11/16/21
Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/10/21
Representatives of Fulgent Genetics to Participate in Upcoming Virtual ConferencesBusiness Wire • 11/09/21
Helio Health and Fulgent Genetics Announce Late-Breaking Positive Performance Data of HelioLiver™ for Early Liver Cancer DetectionPRNewsWire • 11/08/21
Earnings Preview: Fullgent Genetics (FLGT) Q3 Earnings Expected to DeclineZacks Investment Research • 11/02/21
Helio Health and Fulgent Genetics to Present New Data on HelioLiver in Late-Breaking Presentation at The Liver Meeting® 2021PRNewsWire • 11/01/21
Fulgent Genetics to Announce Third Quarter 2021 Financial Results on Tuesday November 9, 2021Business Wire • 10/25/21
Fulgent Genetics to Partner with Houston Health Department and Houston-Area Public Schools on Back-to-School COVID-19 Testing ProgramBusiness Wire • 09/23/21